Red cell alloimmunization in multi-transfused patients with sickle cell anemia in Benin City, Nigeria

Nigerian Journal of Clinical Practice

Volumn 18, Issue 4, 2015, Pages 522-526

  Ugwu, N I ^a   Awodu, O A ^b   Bazuaye, G N ^b   Okoye, A E ^a  

^a EBONYI STATE UNIVERSITY   (Nigeria)

^b UNIVERSITY OF BENIN   (Nigeria)

Author keywords

Alloimmunization; blood transfusion; sickle cell anemia

Indexed keywords

ALLOANTIBODY;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD; BLOOD GROUP TYPING; CROSS-SECTIONAL STUDY; ERYTHROCYTE TRANSFUSION; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; PROCEDURES; YOUNG ADULT;

ADOLESCENT; ADULT; ANEMIA, SICKLE CELL; BLOOD GROUPING AND CROSSMATCHING; CROSS-SECTIONAL STUDIES; ERYTHROCYTE TRANSFUSION; FEMALE; HUMANS; ISOANTIBODIES; MALE; MIDDLE AGED; NIGERIA; PREVALENCE; YOUNG ADULT;

EID: 84929627585     PISSN: 11193077     EISSN: None     Source Type: Journal    
DOI: 10.4103/1119-3077.154204     Document Type: Article

References (24)

1. Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: An increasing global health problem. Bull World Health Organ 2001;79:704-12.
2. Roberts I, de Montalembert M. Sickle cell disease as a paradigm of immigration hematology: New challenges for hematologists in Europe. Haematologica 2007;92:865-71.
3. WHO. Sickle Cell Anemia. Report by the Secretariat of the Fifty-Ninth World Health Assembly A59/9. Geneva: WHO; 2006.
4. Akinkugbe OO. Sickle cell disease. In: Akinkugbe OO, editor. Non-communicable Disease in Nigeria. 1st ed. Lagos: Federal Ministry of Health; 1992. p. 45-52.
5. Hsieh MM, Kang EM, Fitzhugh CD, Link MB, Bolan CD, Kurlander R, et al. Allogeneic hematopoietic stem-cell transplantation for sickle cell disease. N Engl J Med 2009;361:2309-17.
6. Davies SC, Olatunji PO. Blood transfusion in sickle cell disease. Vox Sang 1995;68:145-51.
7. Kaliyu-Gwazo A, Akanmu AS, Dutse AI. Prevalence of red cell alloantibodies in multi-transfused patients with sickle cell anaemia in Northern Nigeria. Afr Sanguine 2005;8:1-4.
8. Natukunda B, Schonewille H, Ndugwa C, Brand A. Red blood cell alloimmunization in sickle cell disease patients in Uganda. Transfusion 2010;50:20-5.
9. Reem A, Ohoo A, Salem A, Rafiqul C, Abdulaziz A. Frequency of red cell alloantibody in Kuwait population. Int J Kuwait Univ Health Sci Cent 2005;14:230-4.
10. Murao M, Viana MB. Risk factors for alloimmunization by patients with sickle cell disease. Braz J Med Biol Res 2005;38:675-82.
11. Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617-21.
12. Vichinsky E. Transfusion therapy. In: Embury SH, Hebbel RP, Mohandas N, Steinberg editors. Sickle Cell Disease: Basic Principles and Clinical Practice. New York: Raven Press Ltd.; 1994. p. 781-98.
13. Josephson CD, Su LL, Hillyer KL, Hillyer CD. Transfusion in the patient with sickle cell disease: A critical review of the literature and transfusion guidelines. Transfus Med Rev 2007;21:118-33.
14. Scheunemann LP, Ataga KI. Delayed hemolytic transfusion reaction in sickle cell disease. Am J Med Sci 2010;339:266-9.
15. Avent ND, Reid ME. The Rh blood group system: A review. Blood 2000;95:375-87.
16. Werbert KE, Chan HH, Smith JW, Heddie NM, Kelton JG. Red cell, platelet and white cell antigens. In: Greer JP, Foerster J, Lukens J, editors. Wintrobe's Clinical Haematology. 11th ed. Philadelphia: Lippincott Williams and Wilkins; 2003. p. 643-65.
17. Reid ME, Calhoun L, Petz LD. Erythrocyte antigens and antibodies. In: Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Kaushausky K, Prchal JT, editors. Williams Haematology. 7th ed. USA: McGraw-Hill; 2006. p. 2119-36.
18. Vaughan JI, Warwick R, Letsky E, Nicolini U, Rodeck CH, Fisk NM. Erythropoietic suppression in fetal anemia because of Kell alloimmunization. Am J Obstet Gynecol 1994;171:247-52.
19. Vaughan JI, Manning M, Warwick RM, Letsky EA, Murray NA, Roberts IA. Inhibition of erythroid progenitor cells by anti-Kell antibodies in fetal alloimmune anemia. N Engl J Med 1998;338:798-803.
20. Daniels G, Hadley A, Green CA. Causes of fetal anemia in hemolytic disease due to anti-K. Transfusion 2003;43:115-6.
21. Toly-Ndour C, Rouquette AM, Obadia S, M'bappe P, Lionnet F, Hagege I, et al. High titers of autoantibodies in patients with sickle-cell disease. J Rheumatol 2011;38:302-9.
22. Olujohungbe A, Hambleton I, Stephens L, Serjeant B, Serjeant G. Red cell antibodies in patients with homozygous sickle cell disease: A comparison of patients in Jamaica and the United Kingdom. Br J Haematol 2001;113:661-5.
23. Pinto PC, Braga JA, Santos AM. Risk factors for alloimmunization in patients with sickle cell anemia. Rev Assoc Med Bras 2011;57:668-73.
24. Schonewille H, Van De Watering LM, Loomans DS, Brand A. Red blood cell alloantibodies after transfusion: Factors influencing incidence and specificity. Transfusion 2006;46:250-6.